Pattern of Use and Outcomes with Donor Lymphocyte Infusion (DLI) and Unmanipulated Stem Cell Boost (SCB) after Allogeneic Hematopoietic Stem Cell Transplant (HSCT): A Single-Center Experience

被引:0
|
作者
Bukhari, Ali [1 ]
Dahiya, Saurabh [1 ]
Goloubeva, Olga [1 ]
Yip, Terry [1 ]
Rapoport, Aaron P. [1 ]
Hardy, Nancy M. [1 ]
Badros, Ashraf [1 ]
Kocoglu, Mehmet H. [1 ]
Emadi, Ashkan [1 ]
El-Chaer, Firas [1 ]
Holtzman, Noa G. [1 ]
Minas, Nicolette M. [1 ]
Ruehle, Kathleen [1 ]
Yared, Jean A. [1 ]
机构
[1] Univ Maryland, Baltimore, MD 21201 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
356
引用
收藏
页数:2
相关论文
共 50 条
  • [1] DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN: SINGLE CENTER EXPERIENCE
    Park, J. E.
    Lee, K. C.
    Jung, H. J.
    Lee, S. W.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S494 - S494
  • [2] Donor Lymphocyte Infusion after Allogeneic Hematopoietic Stem Cell Transplantation. Single Centre Experience
    Iturrate, Isabel
    Ruiz, Analys
    Martinez, Sara
    Garcia-Leon, Natalia
    Royg, Mercedes
    Figuera, Angela
    Alegre, Adrian
    Aguado, Beatriz
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 272 - 273
  • [3] Isavuconazole (ISA) use in Adult Allogeneic Hematopoietic Stem Cell Transplant (ALLO-HSCT) Recipients: A single-center Experience
    Tricarico, Sara
    Terenzi, Adelmo
    Pierini, Antonio
    Ruggeri, Loredana
    Felicini, Rita
    Casarola, Genni
    Camerini, Chiara
    Paradiso, Matteo
    Bonato, Samanta
    Griselli, Mario
    Goffredo, Bianca Maria
    Velardi, Andrea
    Carotti, Alessandra
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 498 - 499
  • [4] Donor lymphocyte infusion administrations after allogeneic stem cell transplantations in pediatrics: A single center experience
    Aydogdu, Selime
    Mergen, Azize
    Aksoy, Basak
    Akbay, Hazal S.
    Cipe, Funda
    Dikme, Gurcan
    Fisgin, Tunc
    Bozkurt, Ceyhun
    BONE MARROW TRANSPLANTATION, 2019, 54 : 196 - 196
  • [5] Outcomes after second allogeneic hematopoietic stem cell transplantation: A single-center experience.
    Touma, Waseem
    Koro, Sami S.
    Bhamidipati, Pavan Kumar
    Manjappa, Shivaprasad
    Romee, Rizwan
    Pusic, Iskra
    Uy, Geoffrey L.
    Cashen, Amanda F.
    Stockerl-Goldstein, Keith
    Westervelt, Peter
    Bboud, Camille N. A.
    Vij, Ravi
    DiPersio, John F.
    Schroeder, Mark A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] The effect of donor lymphocyte infusions (DLI) on chimerism and persistent disease after nonmyeloblative hematopoietic stem cell transplant (HSCT).
    Maris, MB
    Sandmaier, BM
    Niederwieser, D
    Maloney, DG
    McSweeney, PA
    Chauncey, T
    Shizuru, J
    Sahebi, F
    Blume, K
    Forman, S
    Storb, R
    BLOOD, 2000, 96 (11) : 477A - 477A
  • [7] Donor Lymphocyte Experience in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients
    Warneke, Stacey
    Jaroscak, Jennifer Joi
    Donahoo, Lori Burton
    Kramer, Cindy
    Judd, Leah
    Hudspeth, Michelle
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S415 - S415
  • [8] Flag-Ida and donor lymphocyte infusion (DLI) for acute leukemia relapse after allogeneic stem cell transplantation (alloSCT) - single center experience
    Radocha, Jakub
    Zavrelova, Alzbeta
    Lanska, Miriam
    Visek, Benjamin
    Horacek, Jan M.
    Zak, Pavel
    BONE MARROW TRANSPLANTATION, 2018, 53 : 164 - 165
  • [9] Inotuzumab Ozogamicin (IO) and Donor Lymphocyte Infusion (DLI) are a Safe and Promising Combination in Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT)
    Papayannidis, Cristina
    Sartor, Chiara
    Dominietto, Alida
    Zappone, Elisabetta
    Marconi, Giovanni
    Abbenante, Maria Chiara
    Parisi, Sarah
    Robustelli, Valentina
    Terragna, Carolina
    Nanni, Jacopo
    Soverini, Simona
    Cristiano, Gianluca
    Arpinati, Mario
    Paolini, Stefania
    Martinelli, Giovanni
    Curti, Antonio
    Cavo, Michele
    Bonifazi, Francesca
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S161 - S161
  • [10] Long-term safety and survival outcomes after TK-expressing donor lymphocyte infusion (TK-DLI) in allogeneic hematopoietic stem cell transplantation (HSCT).
    Ciceri, Fabio
    Lupo-Stanghellini, Maria Teresa
    Oliveira, Giacomo
    Greco, Raffaella
    Vago, Luca
    Bondanza, Attilio
    Lambiase, Antonio
    Bordignon, Claudio
    Bonini, Chiara
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)